机体:对心血管系统的潜在有益影响
Kunihiko Aizawa1,2, Takashi Nakamura3, Yasuhiro Shimada3
1Department of Clinical and Biomedical Sciences, University of Exeter Medical School, Exeter, UK.
Physiological reports
|February 5, 2025
概括
聚变-[(2-碳氧乙烯) 基马斯基) (Ge-132) 除了免疫支持之外,还提供了独特的心血管益处. 这种有机化合物表现出性作用,包括增强红细胞生命周期,有利于血管功能和氧气输送.
科学领域:
- 生物化学 生物化学
- 心血管科学 心血管科学
- 免疫学 免疫学 免疫学
背景情况:
- 有机化合物,特别是聚变-[(2-碳氧乙烯) (Ge-132),已被认为具有免疫调节作用.
- 新出现的证据表明Ge-132具有独特的,低估的多功能性质,具有潜在的心血管益处.
研究的目的:
- 审查各种体内和体外证据,强调Ge-132对心血管系统的潜在积极影响.
- 阐明Ge-132与心血管健康相关的类生理效应背后的分子机制.
主要方法:
- 对Ge-132与生物分子 (vicinal diols) 的相互作用现有文献的分析.
- 检查Ge-132对巨细胞化和血红素代谢途径的影响.
- 详细介绍Ge-132的生理作用,包括抗氧化,抗炎症和红细胞生命周期增强等研究的综述.
主要成果:
- Ge-132与ATP,甲醇胺和葡萄糖等必不可少的生物分子中发现的邻近二醇形成复合体.
- 基-132可以调节血红素代谢途径中的酶,增加细胞保护性分子 (比利韦丁,比利鲁宾).
- 口服Ge-132的摄入会产生抗氧化,抗炎症,抗高血压,抗糖化和改善红细胞生命周期的性作用.
结论:
- Ge-132 具有多功能性质,通过各种生理效应对心血管系统产生积极影响.
- 通过Ge-132增强红细胞生命周期对于血管功能,氧气输送和红细胞生成至关重要.
- 需要进一步的人类研究来证实这些有益效应在临床环境中的转化.
相关概念视频
Heart Failure Drugs: Inotropic Agents
505
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
505
Antianginal Drugs: Nitrates and β-Blockers
509
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
509
The Periodic Table and Organismal Elements
174.9K
Overview
174.9K
Adrenergic Antagonists: ɑ and β-Receptor Blockers
404
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
404
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
528
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
528
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
375
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
375


